FDA Seeks Public Comment on Real-World AI Medical Device Performance
The agency is requesting public comment on methods for monitoring and evaluating AI models after deployment to ensure continued safety and effectiveness.
The agency is requesting public comment on methods for monitoring and evaluating AI models after deployment to ensure continued safety and effectiveness.
Boston Scientific’s Endotak Reliance leads with ePTFE-coated coils may reduce shock efficacy due to coil calcification.
Designed to reduce imaging artifacts during neurosurgery, the SonoClear System now has FDA Breakthrough Device status and is moving toward 510(k) submission.
The agency is requesting public comment on methods for monitoring and evaluating AI models after deployment to ensure continued safety and effectiveness.
The FDA will expand generative AI tools across all centers by June 30 following a successful scientific review pilot, aiming to reduce repetitive tasks and improve operational efficiency.
Read MoreThe FDA is ramping up unannounced inspections at foreign sites producing medical products and other goods to align regulatory oversight with domestic standards.
Read MoreChanges in suppliers and manufacturing locations to avoid tariffs can require new regulatory filings, increasing time and cost burdens across global markets.
Read MoreA former FDA official argues that medical device repair needs stricter oversight to protect patient safety amid growing right to repair efforts.
Read MoreThe FDA has issued a warning letter to ICU Medical, citing regulatory violations related to unapproved modifications to two of its infusion pumps.
Read MoreAAMI has named the advisory council and selected a venue for its 2026 medical device standards-focused conference.
Read MoreNew framework calls for clear regulatory pathways, data access reform, and reimbursement strategies to advance AI-enabled medical devices.